Selectis Health Provides Business Update
Selectis Health Provides Business Update
- First Quarter 2022 Revenue Increased Over 75% Year-over-Year -
-2022年第一季度收入同比增长75%以上 -
- Sustained Census and Operational Improvements Drive Strategic Progress Through the First Half of 2022 -
- 持续的人口普查和业务改进驾驶战略进展 穿过2022年上半年-
- Christine Lucus Appointed as Interim Chief Financial Officer -
--克里斯汀卢卡斯 已获委任作为临时首席财务官-
- Appointment of David Furstenberg to Board of Directors Establishes Standing Audit Committee and Strengthens Corporate Governance Structure -
- 任命大卫·弗斯滕伯格为董事会成员成立常设审计委员会 并加强企业管治结构 -
Greenwood Village, Colorado, July 11, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") is providing a business update on its recent strategic and operational highlights through the second quarter of 2022.
科罗拉多州格林伍德村,2022年7月11日(环球通讯社)Selectis Health,Inc.(场外交易代码:GBCS)(“Selectis”或“公司”)正在提供2022年第二季度之前其最近的战略和运营重点的最新业务情况。
"While we are not yet able to report our 2021 financial results, we have continued to make strong progress on improving patient census across our portfolio and optimizing the efficiency of our operations," said Lance Baller, CEO of Selectis. "Based on our internally prepared financial statements, which have yet to be reviewed, our revenue in the first quarter of 2022 increased by over 75% year-over-year, sustaining the top-line growth momentum we drove during 2021 and demonstrating the success of our ongoing business transformation strategy.
Selectis首席执行官兰斯·巴勒表示:“虽然我们还无法报告2021年的财务业绩,但我们在改善我们整个投资组合的患者普查和优化我们的运营效率方面继续取得了强劲的进展。”根据我们内部编制的财务报表(尚未审查),我们在2022年第一季度的收入同比增长超过75%,保持了我们在2021年推动的营收增长势头,并展示了我们正在进行的业务转型战略的成功。
"As we have previously disclosed, the completion of our 2021 financial statements audit has been delayed by various audit field work challenges, and this has subsequently delayed the filing of our first quarter 2022 10-Q. We agree with our shareholders that these delays are unacceptable and are committed to taking the necessary actions to ensure that they will not be repeated in the future. Once our audited financial statements are filed, we will schedule our annual shareholder meeting and resume our regular reporting and communications cadence. We remain focused on completing the independent audit of our financial statements and becoming current on our SEC filings as soon as practicable."
“正如我们之前披露的那样,由于各种审计现场工作的挑战,我们2021年财务报表审计的完成被推迟了,这也推迟了我们2022年第一季度10-Q的提交。我们同意我们股东的观点,这些延迟是不可接受的,并致力于采取必要的行动,以确保未来不会再次发生这种情况。一旦我们提交了经审计的财务报表,我们将安排年度股东大会,并恢复我们定期的报告和沟通节奏。我们仍然专注于完成对我们财务报表的独立审计,并尽快掌握我们美国证券交易委员会报告的最新情况。”
Recent Operational Highlights (Through Q2 2022)
最近投入运营亮点(到2022年第二季度)
Facility Footprint
设施占地面积
- Assumed full operational control of Warrenton and Sparta facilities in December 2021.
- Entered 2022 with nine of the Company's 13 owned facilities under its full operational control, compared to five owned and controlled facilities in 2020.
- Converted Park Place facility financing to a five-year term loan during the second quarter of 2022.
- Secured direct Medicaid and Medicare billing approvals from the Centers for Medicare & Medicaid Services (CMS) for all of the Company's operated facilities—including newly opened buildings—by the end of the second quarter of 2022.
- 于2021年12月全面控制沃伦顿和斯巴达设施的运营。
- 进入2022年时,公司拥有的13个设施中有9个处于全面运营控制之下,而2020年拥有和控制的设施为5个。
- 在2022年第二季度将Park Place设施融资转换为五年期定期贷款。
- 在2022年第二季度末之前,获得医疗保险和医疗补助服务中心(CMS)对公司所有运营设施(包括新开业的建筑)的直接医疗补助和医疗保险账单批准。
Census Growth
人口普查 生长
- Reached record patient census at Warrenton as of the first quarter of 2022, with over 56 patients currently in residence.
- Increased census at Park Place facility to over 25 patients in the second quarter of 2022.
- Surpassed 40 residents at Southern Hills independent living facility. Census at this facility is expected to reach full capacity (90 residents) by the end of the first quarter of 2023.
- 截至2022年第一季度,沃伦顿的患者普查达到创纪录的水平,目前有超过56名患者居住。
- 2022年第二季度,公园广场设施的人口普查增加到超过25名患者。
- 南山独立生活设施的40多名居民。该设施的人口普查预计将在2023年第一季度末达到满负荷(90名居民)。
New Hires
新员工
- Hired two full-time corporate recruiters focused on accelerating the Company's internal hiring program. Selectis continues to focus on staffing buildout across its facility footprint, with the goal of eliminating third-party agency staffing needs by year-end 2022.
- Hired two new facility-level executive directors at Sparta and Park Place, as well as a director of nursing and a marketing director at Park Place.
- Hired full-time marketing leaders for Southern Hills independent living and skilled nursing facilities.
- 聘请了两名全职企业招聘人员,专注于加快公司的内部招聘计划。Selectis继续专注于整个设施的人员配备,目标是在2022年底之前消除第三方机构的人员配备需求。
- 在斯巴达和Park Place聘请了两名新的设施级执行董事,并在Park Place聘请了一名董事护理人员和一名营销人员。
- 为南山独立的生活和熟练的护理设施聘请了全职营销主管。
Randy Barker, President and COO of Selectis, commented: "Through the first half of 2022, we have continued to implement key operational upgrades to enhance our capacity and patient mix throughout our portfolio. By the beginning of this year, we had nine of our 13 owned facilities under our full operational control, as we assumed operations at both Warrenton and Sparta in December 2021 after receiving final CMS approval to allow direct Medicaid and Medicare billing. We now have complete Medicaid and Medicare billing approvals for all of our operated facilities, and we will continue working to optimize our patient mix across our footprint to drive towards portfolio-wide profitability.
Selectis的兰迪·巴克、总裁和首席运营官兰迪·巴克、总裁和首席运营官表示:“在2022年上半年,我们继续实施关键的运营升级,以增强我们整个投资组合的能力和患者组合。到今年年初,我们拥有13家机构中的9家处于完全运营控制之下,我们在获得CMS最终批准允许直接医疗补助和医疗保险账单后,于2021年12月在沃伦顿和斯巴达同时运营。我们现在已经为我们运营的所有设施获得了完整的医疗补助和联邦医疗保险账单审批,我们将继续努力优化我们的患者组合,以推动整个投资组合的盈利。
"Despite Omicron variant-related impacts at our facilities during the fourth quarter of 2021 and into the first quarter of 2022, we have since driven census improvements across our facilities. Patient census at our Warrenton facility reached record levels in the first quarter, and we generated strong growth at our Park Place facility and Southern Hills independent living facility during the second quarter.
尽管在2021年第四季度和2022年第一季度,我们的设施受到了与奥密克戎相关的影响,但自那以来,我们推动了我们设施的人口普查工作的改善。我们沃伦顿设施的患者普查在第一季度达到了创纪录的水平,我们的Park Place设施和南山独立生活设施在第二季度实现了强劲增长。
"We have also worked to expand our facility-level recruiting, personnel, and leadership teams to support additional patient growth and reduce our need for temporary third-party agency nursing staff. Our agency usage was driven by pandemic-related needs and nursing staff shortages across our industry, and these higher third-party wage rates have increased our operating expenses through 2021 and into 2022. As we bolster our internal hiring efforts, we aim to eliminate our agency spending by the end of this year, which will improve our progress towards profitability and continue strengthening our operational infrastructure.
我们还努力扩大我们设施级别的招聘、人员和领导团队,以支持更多的患者增长,并减少我们对临时第三方机构护理人员的需求。我们机构的使用是由整个行业与流行病相关的需求和护理人员短缺推动的,这些较高的第三方工资率增加了我们从2021年到2022年的运营费用。随着我们加强内部招聘努力,我们的目标是在今年年底之前减少机构支出,这将改善我们在盈利方面的进展,并继续加强我们的运营基础设施。
"As we enter the second half of 2022, we will work to further advance our business transformation strategy and enhance the quality of care we provide for our patients and residents. Across our organization, we remain focused on our core operational goals of maximizing patient census, optimizing Medicare and Medicaid patient mix, and achieving profitability for our full portfolio. We look forward to providing further updates as we finalize our independent audit and make additional strategic progress."
随着我们进入2022年下半年,我们将努力进一步推进我们的业务转型战略,并提高我们为患者和居民提供的护理质量。在整个组织中,我们仍然专注于我们的核心运营目标,即最大限度地扩大患者普查,优化联邦医疗保险和医疗补助患者组合,并实现我们整个投资组合的盈利。我们期待在完成独立审计和取得更多战略进展时提供进一步的最新情况。
Appointment of Christine Lucus as Interim Chief Financial Officer
委任克莉丝汀卢卡斯担任临时首席财务官
Effective March 5, 2022, Selectis has appointed Christine Lucus as the Company's interim Chief Financial Officer.
从2022年3月5日起,Selectis已任命克里斯汀·卢卡斯为公司临时首席财务官。
Lucus joined the Company as Controller in 2021 and has nearly a decade of financial experience in the health and pharmaceutical industries. Before joining Selectis, she served as Controller for Neubase Therapeutics, Inc., where she focused on financial statement preparations and reporting, as well as benefits administration. Prior to Neubase Therapeutics, Lucus was the accounting and HR manager for Drug Delivery, Inc. She holds a B.S. in Accounting from San Diego State University, where she served as VP of activities in student accountancy.
卢卡斯于2021年加入公司担任财务总监,在健康和制药行业拥有近十年的财务经验。在加入Selectis之前,她曾担任Neubase治疗公司的财务总监,在那里她专注于财务报表准备和报告以及福利管理。在加入Neubase治疗公司之前,卢卡斯是药物输送公司的会计和人力资源经理。她拥有圣地亚哥州立大学的会计学学士学位,并在那里担任学生会计活动副总裁。
Baller continued: "Having Christine on our executive team has helped drive our sustained progress on our strategic initiatives. With her strong financial reporting and health industry background, she has made meaningful contributions to Selectis throughout her tenure with the Company. As we progress further into 2022, we look forward to continuing our work with Christine to make additional headway on our longer-term vision."
鲍尔继续说道:“让克里斯汀加入我们的执行团队,帮助推动了我们在战略举措上的持续进步。凭借她强大的财务报告和健康行业背景,她在公司任职期间为Selectis做出了有意义的贡献。随着我们进一步迈向2022年,我们期待着继续与Christine合作,在我们的长期愿景上取得更大进展。”
Appointment of David Furstenberg to Board of Directors
任命大卫·弗斯滕伯格为董事会成员
Effective July 1, 2022, Selectis has appointed David Furstenberg to its board of directors. Furstenberg will serve on the Company's standing audit committee and qualify as the audit committee's financial expert, as defined in Item 401(h) of Regulation S-K.
自2022年7月1日起,Selectis已任命大卫·弗斯滕伯格为董事会成员。根据S-K条例第401(H)项的规定,弗斯滕伯格将在公司常设审计委员会任职,并有资格成为审计委员会的财务专家。
Furstenberg is a tax attorney and certified public accountant with over 35 years of experience in tax research and planning, accounting, state and federal tax returns, and auditor relations. He previously served as the director of taxes at PulteGroup, where he led the federal, state, and international tax research and planning functions from 1997 to 2016. Prior to his role at PulteGroup, Furstenberg held the roles of assistant vice president – taxes, director of taxes, and director of federal taxes at Handleman Company. He has also served as an associate attorney at Levin, Levin, Garvett & Dill, PC and as a tax consultant and tax associate at Price Waterhouse. Furstenberg holds a B.A. in Accounting from Michigan State University and a J.D. from Wayne State University Law School.
弗斯滕伯格是一名税务律师和注册会计师,在税务研究和规划、会计、州和联邦纳税申报单以及审计师关系方面拥有超过35年的经验。他之前曾在PulteGroup担任税务部门的董事,1997年至2016年期间,他在PulteGroup领导联邦、州和国际税务研究和规划职能。在PulteGroup任职之前,她曾在Handleman公司担任税务助理总裁、税务部门的董事和联邦税务部门的董事。他还曾担任Levin,Levin,Garvett&Dill,PC律师事务所的副律师,以及普华永道的税务顾问和税务助理。弗斯滕伯格拥有密歇根州立大学会计学学士学位和韦恩州立大学法学院法学博士学位。
Baller concluded: "With his extensive accounting, legal, and public company experience, David brings a seasoned perspective to our board at a key time in our business transformation. His appointment enables us to establish our standing audit committee, which strengthens our financial controls and corporate governance structure as we work towards up-listing on a national exchange. We look forward to leveraging David's expertise as we continue working to progress our growth objectives and establish Selectis as a top-quality senior healthcare provider within the Southcentral and Southeastern U.S."
鲍尔总结道:“凭借其丰富的会计、法律和上市公司经验,大卫在我们业务转型的关键时刻为我们的董事会带来了经验丰富的视角。他的任命使我们能够建立我们的常设审计委员会,该委员会在我们努力在全国交易所上市的过程中加强我们的财务控制和公司治理结构。我们期待着利用大卫的专业知识,继续努力实现我们的增长目标,并将Selectis确立为美国中南部和东南部的一家顶级高级医疗保健提供商。”
About Selectis Health
Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.
关于Selectis健康状况
Selectis Health在阿肯色州、佐治亚州、俄亥俄州和俄克拉何马州拥有和/或运营医疗设施,提供广泛的生活服务、语言、职业、物理治疗、社会服务以及其他康复和医疗服务。Selectis专注于与当地社区建立战略关系,在这种关系中,它的伙伴关系可以提高设施居民的护理质量。凭借其专注的增长战略,Selectis打算深化其在美国中南部和东南部的市场份额,以更好地为老龄化人口提供全方位的护理服务。
For more information, please visit .
欲了解更多信息,请访问。
Forward Looking Statements
前瞻性陈述
This press release contains statements that plan for or anticipate the future. In this press release, forward-looking statements are generally identified by the words "anticipate," "plan," "believe," "expect," "estimate," and the like. These forward-looking statements include, but are not limited to, statements regarding the following:
本新闻稿包含对未来进行计划或预期的陈述。在本新闻稿中,前瞻性陈述通常由“预期”、“计划”、“相信”、“预期”、“估计”等词来识别。这些前瞻性陈述包括但不限于关于以下方面的陈述:
* | strategic business relationships; | |
* | statements about our future business plans and strategies; | |
* | anticipated operating results and sources of future revenue; | |
* | our organization's growth; | |
* | adequacy of our financial resources; | |
* | development of markets; | |
* | competitive pressures; | |
* | changing economic conditions; and, | |
* | expectations regarding competition from other companies. | |
* | the duration and scope of the COVID-19 pandemic | |
* | the impact of the COVID-19 pandemic on occupancy rates and on the operations of the Company's facilities. | |
* | Actions governments take in response to the COVID-19 pandemic, including the introduction of public health measures and other regulations affecting our properties and our operations. | |
* | The effects of health and safety measures adopted by us in response to the COVID-19 pandemic. | |
* | Increased operational costs because of health and safety measures related to COVID-19. | |
* | Disruptions to our property acquisition and disposition activities due to economic uncertainty caused by COVID-19. | |
* | General economic uncertainty in key markets as a result of the COVID-19 pandemic and a worsening of global economic conditions or low levels of economic growth. |
* | 战略业务关系; | |
* | 关于我们未来业务计划和战略的声明; | |
* | 预期经营业绩和未来收入来源; | |
* | 我们组织的成长; | |
* | 我们的财政资源是否足够; | |
* | 开拓市场; | |
* | 竞争压力; | |
* | 不断变化的经济状况;以及 | |
* | 对来自其他公司的竞争的预期。 | |
* | 新冠肺炎大流行的持续时间和范围 | |
* | 新冠肺炎疫情对入住率和公司设施运营的影响。 | |
* | 各国政府为应对新冠肺炎疫情而采取的行动,包括引入公共卫生措施和其他影响我们财产和运营的法规。 | |
* | 我们为应对新冠肺炎大流行而采取的健康和安全措施的影响。 | |
* | 由于与新冠肺炎相关的健康和安全措施,运营成本增加。 | |
* | 由于新冠肺炎带来的经济不确定性,我们的财产收购和处置活动中断。 | |
* | 新冠肺炎疫情以及全球经济状况恶化或经济增长水平低导致主要市场普遍存在经济不确定性。 |
Although we believe that any forward-looking statements, we make in this press release are reasonable, because forward-looking statements involve future risks and uncertainties, there are factors that could cause actual results to differ materially from those expressed or implied. For example, a few of the uncertainties that could affect the accuracy of forward-looking statements, besides the specific factors identified above in the Risk Factors section of this press release, include:
尽管我们认为本新闻稿中的任何前瞻性陈述都是合理的,因为前瞻性陈述涉及未来的风险和不确定因素,但也有可能导致实际结果与明示或暗示的结果大不相同的因素。例如,除了本新闻稿上述风险因素部分确定的具体因素外,可能影响前瞻性陈述准确性的一些不确定因素包括:
* | changes in general economic and business conditions affecting the healthcare industry; | |
* | developments that make our facilities less competitive; | |
* | changes in our business strategies; | |
* | the level of demand for our facilities; and | |
* | regulatory changes affecting the healthcare industry and third-party payor practices. |
* | 影响医疗保健行业的总体经济和商业状况的变化; | |
* | 使我们的设施竞争力下降的发展; | |
* | 我们的经营策略发生了变化; | |
* | 对我们设施的需求水平;以及 | |
* | 影响医疗行业和第三方付款人做法的监管变化。 |
Investor Relations Contact
Scott Liolios or Jackie Keshner
Gateway Group, Inc.
(949) 574-3860
selectis@gatewayir.com
投资者关系联系人
斯科特·利奥里奥或杰基·凯什纳
网关集团公司
(949) 574-3860
邮箱:seltis@gatewayir.com